Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

CV hyperpolarizer facility

  • 1 January 2017 to 1 July 2017
  • Awards: Infrastructure Awards

Hyperpolarized magnetic resonance imaging (HP-MRI) is a new technology that allows the generation of contrast agents, which improve the sensitivity of MRI by more than 10,000-fold. This award has enabled the development of a pharmacy facility to generate these contrast agents in a sterile manor that makes them suitable for human studies.Thus, new approaches can be developed to study human heart disease.

Isolator(CTASU).jpgAndrew Lewis - hyperpolerizer.JPG